Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-166,103
Closed -$20.8M 120
2016
Q3
$20.8M Buy
166,103
+2,467
+2% +$323K 2.3% 30
2016
Q2
$22.6M Buy
163,636
+4,571
+3% +$593K 2.61% 23
2016
Q1
$20.1M Buy
159,065
+2,350
+1% +$299K 2.38% 25
2015
Q4
$19.9M Buy
156,715
+2,630
+2% +$326K 2.59% 21
2015
Q3
$17.8M Buy
+154,085
New +$17.3M 2.49% 26

Other funds holding CLX

Sabal Trust's CLX Position: Q4 2016 in Review

Sabal Trust sold out of Clorox (CLX) in Q4 2016, closing a stake of 166,103 shares — an estimated $20.8M sold.

Sabal Trust first reported a position in CLX in Q3 2015 and held it in 5 quarters. The position peaked at $22.6M in Q2 2016. 838 funds tracked by Wall St. Rank hold CLX as of Q4 2016.

  • Sabal Trust reported no remaining Clorox position as of Q4 2016 after selling out during the quarter.
  • Sabal Trust sold 166,103 Clorox shares in Q4 2016, an estimated $20.8M.
  • Sabal Trust first reported a position in Clorox in Q3 2015 and held it in 5 quarters.
  • Sabal Trust's Clorox position peaked at $22.6M in Q2 2016.
  • 838 funds tracked by Wall St. Rank held Clorox as of Q4 2016.

Based on Sabal Trust's 13F filing for Q4 2016, filed 18 Jan 2017.